CNXU — Conexeu Sciences Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 2066836 ·
Last close
$7.89
Market Cap
52W High
$18.79
52W Low
$7.10
ADV30
107,748
Next earnings
LCNB Corp. operates as the financial holding company for LCNB National Bank that provides banking services in the United States. It offers checking and savings accounts; interest-bearing demand and money market deposit; and time certificates. The company also provides commercial and industrial, commercial and residential real estate, agricultural, construction, various types of consumer, and small business administration loans; residential mortgage loans, such as loans for purchasing or refinancing personal residences, home equity lines of credit, and loans for commercial or consumer purposes secured by residential mortgages; and consumer lending comprising automobile, boat, home improvement, and personal loans. In addition, it offers trust administration, estate settlement, and fiduciary services; and investment management of trusts, agency accounts, individual retirement accounts, and foundations/endowments. Further, the company offers investment services and products, including financial needs analysis, mutual funds, securities trading, annuities, and life insurance; and security brokerage services. Additionally, it provides safe deposit boxes, night depositories, cashier's checks, bank-by-mail, ATMs, cash and transaction services, debit cards, wire transfers, electronic funds transfer, utility bill collections, notary public service, cash management services, telephone banking, PC Internet banking, mobile banking, and other services for individuals and businesses. LCNB Corp. was founded in 1877 and is headquartered in Lebanon, Ohio.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Apr 2026 0 -2,376,724 -2,304,283 8,199,679 6,848,064 1,003,296
Jan 2026 0 -1,720,927 -1,718,823 7,702,677 6,255,388 876,275
Apr 2025 0 -456,055 -458,050
Jan 2025 0 -332,721 -290,064

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,004,886
Investing CF
$-53,099
Financing CF
$6,290,723
CapEx
$-53,097
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.23
As of
2026-06-21

Balance + Analyst (yfinance extras)

Retained Earnings
$-8,544,626
Inventory
Receivables
$2,171
ST Investments
EBIT TTM
$-4,766,227
Pretax Income TTM
$-4,771,220
Interest Exp TTM
$4,993
Analysts

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Oct 2025 0 -3,958,329 -3,923,557 7,688,711 336,018 -1,669,975
Oct 2024 0 -643,042 -471,867 533,940 438,976 -225,439

Peers — same industry

TickerNameMarket CapLastDaily %
SYK STRYKER CORP $135.04B $352.25
ISRG INTUITIVE SURGICAL INC $126.51B $353.10
MDT Medtronic plc $112.06B $87.54
MMM 3M CO $91.77B $177.95
BSX BOSTON SCIENTIFIC CORP $68.43B $46.04

News headlines (Yahoo Finance, 1h cache)

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
2026-07-14 12:30 · Yahoo
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
2026-07-07 13:00 · Yahoo
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
2026-06-25 12:30 · Yahoo
Is Conexeu Sciences (CNXU) Quietly Redefining Its Commercial Ambitions With CXU Platform Moves?
2026-06-19 06:16 · Yahoo
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
2026-06-15 12:30 · Yahoo
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
2026-06-08 12:30 · Yahoo
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
2026-06-04 14:50 · Yahoo
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
2026-06-03 12:30 · Yahoo
How Investors Are Reacting To Conexeu Sciences (CNXU) 3D-Printed Bioregenerative Breast Matrix Initiative
2026-06-02 10:10 · Yahoo
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
2026-05-27 14:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.